Entos Pharmaceuticals Inc

Entos Pharmaceuticals Inc

This company develops nucleic acid delivery technology and genetic medicines for patients with rare diseases and unmet clinical needs.

Entrada Therapeutics

This biopharmaceutical company develops intracellular medicines for patients with neuromuscular and rare diseases using its proprietary endosomal escape vehicle delivery platform.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Engage Bio

This biotechnology company develops non-viral genetic medicines and mRNA immunotherapies for pharmaceutical partners to treat cancer and gene replacement disorders.

Ensoma

This company develops in vivo genomic medicines and vector delivery platforms to engineer blood and immune cells for patients with genetic diseases and cancer.

Alia Therapeutics

The company develops gene editing medicines for patients with genetic diseases.

Sisaf

This company develops RNA delivery technologies and nucleic acid medicines for pharmaceutical partners treating rare genetic diseases and cancers.